Alder BioPharmaceuticals alderbio.com


Public list: Pharma Startups (4734) Cancer Therapeutics (1145)

Alder BioPharmaceuticals identifies, develops and manufactures antibody therapeutics to alleviate human suffering in cancer, pain, cardiovascular and autoimmune and inflammatory disease areas. The company's investigational monoclonal antibody for migraine, ALD403, inhibits a well-validated molecule shown to trigger migraine attacks, calcitonin generelated peptide (CGRP). ALD518 is Alder's investigational monoclonal antibody to the pro-inflammatory cytokine IL-6. Alder is developing ALD518 in Ph...Show all

Alder BioPharmaceuticals identifies, develops and manufactures antibody therapeutics to alleviate human suffering in cancer, pain, cardiovascular and autoimmune and inflammatory disease areas. The company's investigational monoclonal antibody for mig...Show all

Company (IPO / Went public)

Phone: 425-205-2900

Fax:

11804 North Creek Parkway South
Parkway South
Bothell, 98011
Washington, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Alder BioPharmaceuticals $185.1M May 8, 2014

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Alder BioPharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 9 investors
There is no Competitors data available for this company. Please select another tab.